NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding NexImmune, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 39 | 29 | −10 |
| Shares | 7.84M | 5.96M | −1.88M (−24.0%) |
| Value | $4.34M | $1.45M | −$2.89M (−66.6%) |
New holders (3)
Institutions that held NexImmune, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 925,945 | $225.1K | 0.00% |
| Bank of Montreal | 32,000 | $10.9K | 0.00% |
| Virtu Financial LLC | 42,740 | $10.0K | 0.00% |
Sold out (13)
Institutions that held NexImmune, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Slate Path Capital LP | 925,000 | $513.0K |
| FMR LLC | 525,000 | $291.0K |
| Bridger Management, LLC | 400,000 | $222.0K |
| Kettle Hill Capital Management, LLC | 370,691 | $206.0K |
| Brown Brothers Harriman & Co | 122,880 | $68.0K |
| 683 Capital Management, LLC | 100,687 | $56.0K |
| SEI Investments Co | 38,746 | $21.0K |
| Rockefeller Capital Management L.P. | 27,860 | $15.0K |
| Man Group plc | 20,336 | $11.0K |
| Susquehanna International Group, LLP | 13,995 | $8.00K |
| Qube Research & Technologies Ltd | 14,049 | $8.00K |
| BNP Paribas Arbitrage, SA | 1,349 | $748 |
| Royal Bank of Canada | 48 | $0 |